{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:14:36Z","timestamp":1785413676914,"version":"3.56.0"},"reference-count":25,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Angers University Hospital"},{"id":[{"id":"https:\/\/ror.org\/04zn72g03","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Metastatic renal cell carcinoma (mRCC) remains incurable despite advances with immune checkpoint inhibitors and tyrosine kinase inhibitors. Metabolic interventions, such as the ketogenic diet (KD), may modulate tumor biology and systemic inflammation, yet clinical evidence in mRCC is limited. Objective: To evaluate the feasibility, safety, and tolerability of KD combined with systemic therapy in mRCC patients. Design, Setting, and Participants: CETOREIN was a non-randomized, single-center pilot study enrolling 21 adult mRCC patients initiating systemic therapy. KD was initiated concurrently with treatment for up to 12 months, with follow-up at 1, 3, 6, and 12 months. Intervention: Participants followed a 2:1 KD (\u224880% fat, 20% protein + carbohydrates) with dietitian-led counseling, medium-chain triglyceride supplementation, food diaries, and ketonuria monitoring. Outcome Measurements and Statistical Analysis: The primary endpoint was feasibility, defined by diet-related adverse events. Secondary endpoints included adherence, metabolic parameters, and exploratory clinical outcomes (response rate, progression-free survival [PFS], overall survival [OS]). All efficacy-related outcomes were descriptive and exploratory only. Results: Eight patients (40%) completed 12 months on KD, with a mean duration of 7 months. Common diet-related toxicities were diarrhea (55%), weight loss (45%), hypercholesterolemia (40%), and dyspepsia (30%), with no severe events. Early weight loss was modest and transient. Ketonuria correlated with dietary records, confirming adherence. Median PFS was 9.5 months, and median OS was 39 months. Among four patients undergoing cytoreductive nephrectomy, exploratory paired PD-L1 analyses showed decreased expression in three cases; however, these observations are hypothesis-generating only and cannot be attributed to the ketogenic diet. Conclusions: KD is feasible and demonstrated an acceptable tolerability profile in selected mRCC patients, though long-term adherence is challenging. No conclusions regarding antitumor efficacy can be drawn from this small non-randomized pilot study. Future studies should evaluate shorter interventions and optimized dietary protocols in larger randomized trials.<\/jats:p>","DOI":"10.3390\/nu18111712","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:31:56Z","timestamp":1779885116000},"page":"1712","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility and Safety of a Ketogenic Diet During Systemic Therapy for Metastatic Renal Cell Carcinoma: Results from the Cetorein Pilot Study"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7136-9460","authenticated-orcid":false,"given":"Cyrielle","family":"Rolley","sequence":"first","affiliation":[{"name":"Department of Urology, Angers University Hospital, 49333 Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merzouka","family":"Zidane","sequence":"additional","affiliation":[{"name":"Department of Pathology, Angers University Hospital, 49333 Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmina","family":"Nedelcu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Angers University Hospital, 49333 Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Barth","sequence":"additional","affiliation":[{"name":"Department of Genetics, Angers University Hospital, 49333 Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Saulnier","sequence":"additional","affiliation":[{"name":"Department of Statistics, Angers University Hospital, 49333 Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1537-4684","authenticated-orcid":false,"given":"Vincent","family":"Procaccio","sequence":"additional","affiliation":[{"name":"Department of Genetics, Angers University Hospital, 49333 Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5669-9020","authenticated-orcid":false,"given":"Pierre","family":"Bigot","sequence":"additional","affiliation":[{"name":"Department of Urology, Angers University Hospital, 49333 Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","article-title":"European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update","volume":"87","author":"Bex","year":"2025","journal-title":"Eur. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Xu, H., Tu, B., Li, H., and Shan, Y. (2025). From chronic inflammation to immune escape: Mapping the tumor microenvironment evolution in renal cell carcinoma. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1683844"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Creighton","year":"2013","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cmet.2018.07.020","article-title":"Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo","volume":"28","author":"Courtney","year":"2018","journal-title":"Cell Metab."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ebrahimi, H., Battle, D., Salgia, N.J., Zengin, Z.B., Dizman, N., Meza, L., Bergerot, C.D., Barragan-Carrillo, R., Hsu, J., and Castro, D. (2024). Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy. Nutrients, 16.","DOI":"10.3390\/nu16111630"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kaiser, A., Siddiqui, M.M., Bosley-Smith, J., Wang, S., Aryankalayil, J., Mishra, M.V., Ryan, A.S., and D\u2019adamo, C.R. (2024). Weight Loss, Pathological Changes, and Inflammatory Effects from a Short-Term Ketogenic Diet in Overweight and Obese Men with Untreated Prostate Cancer on Active Surveillance. Nutrients, 16.","DOI":"10.3390\/nu16213716"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s40620-025-02285-7","article-title":"Ketogenic diets in chronic kidney disease patients: A review for skeptics by skeptics","volume":"38","author":"Giannese","year":"2025","journal-title":"J. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2008.01821.x","article-title":"History of the ketogenic diet","volume":"49","author":"Wheless","year":"2008","journal-title":"Epilepsia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ejcn.2013.116","article-title":"Beyond weight loss: A review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets","volume":"67","author":"Paoli","year":"2013","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","article-title":"Ketogenic diet in the treatment of cancer\u2013Where do we stand?","volume":"33","author":"Weber","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.redox.2014.08.002","article-title":"Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism","volume":"2","author":"Allen","year":"2014","journal-title":"Redox Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1210\/edrv.21.3.0399","article-title":"The effects of insulin-like growth factors on tumorigenesis and neoplastic growth","volume":"21","author":"Khandwala","year":"2000","journal-title":"Endocr. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/eci.12591","article-title":"Ketogenic diets: From cancer to mitochondrial diseases and beyond","volume":"46","author":"Branco","year":"2016","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Woolf, E.C., Curley, K.L., Liu, Q., Turner, G.H., Charlton, J.A., Preul, M.C., and Scheck, A.C. (2015). The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma Model. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130357"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Nakamura, K., Tonouchi, H., Sasayama, A., and Ashida, K. (2018). A Ketogenic Formula Prevents Tumor Progression and Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice. Nutrients, 10.","DOI":"10.3390\/nu10020206"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Monda, A., La Torre, M.E., Messina, A., Di Maio, G., Monda, V., Moscatelli, F., De Stefano, M., La Marra, M., Di Padova, M., and Dipace, A. (2024). Exploring the ketogenic diet\u2019s potential in reducing neuroinflammation and modulating immune responses. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1425816"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Richard, J., Beauvillain, C., Benoit, M., Barth, M., Aubert, C., Rolley, C., Bellal, S., Bourreau, J., Ferragu, M., and Lebdai, S. (2024). Ketogenic diet enhances the anti-cancer effects of PD-L1 blockade in renal cell carcinoma. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1344891"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ejpn.2016.07.009","article-title":"Ketogenic diet guidelines for infants with refractory epilepsy","volume":"20","author":"Neal","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update","volume":"39","author":"Schneider","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s12020-014-0192-3","article-title":"Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity","volume":"47","author":"Moreno","year":"2014","journal-title":"Endocrine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ajcn\/87.1.44","article-title":"Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum","volume":"87","author":"Johnstone","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"22805","DOI":"10.1038\/s41598-024-73384-x","article-title":"The ketogenic diet has the potential to decrease all-cause mortality without a concomitant increase in cardiovascular-related mortality","volume":"14","author":"Qu","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/CEJ.0000000000000918","article-title":"The effects of the ketogenic diet on cancer treatment: A narrative review","volume":"34","author":"Deng","year":"2025","journal-title":"Eur. J. Cancer Prev."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/11\/1712\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:01:52Z","timestamp":1780574512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/11\/1712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["nu18111712"],"URL":"https:\/\/doi.org\/10.3390\/nu18111712","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}